PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
5 hedge funds and large institutions have $15.6K invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 34 closing their positions.
Holders
5
Holders Change
-33
Holders Change %
-86.84%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
34
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HLA
1
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
$1K |